Nuvation Bio Inc.
NUVB | NYSE
$6.09
+$0.02 (+0.33%)
Sep 22, 2026, 9:33 AM ET · Market open
Market Data
Market Cap $2.11B
Enterprise Value $1.7B
Beta 1.53
Average Volume 6.11M
Shares Outstanding (Diluted) 348.77M
Shares Change YoY 2.35%
Institutional Ownership 63.52%
Exchange NYSE
ISIN US67080N1019
Price Performance
Price Change 1M -11.0%
Price Change 3M 0.5%
Price Change 6M 38.6%
Price Change YTD -29.3%
Price Change 1Y 85.6%
Price Change 3Y 356.4%
Price Change 5Y -35.0%
1M CAGR (ann.) -8.0%
1Y CAGR (ann.) 91.5%
5Y CAGR (ann.) -8.2%
All-Time CAGR -7.9%
Valuation
PE Ratio -13.80
Forward PE N/A
PEG Ratio -0.43
Forward PEG 0.28
PS Ratio 12.40
Forward PS 7.60
PB Ratio 8.30
P/FCF Ratio -25.48
P/Adj. FCF Ratio -33.54
P/OCF Ratio -25.29
EV/Sales 10.00
EV/EBIT -13.15
EV/EBITDA -13.37
EV/FCF -20.53
Earnings Yield -7.3%
FCF Yield -3.9%
Adj. FCF Yield -3.0%
Financial Health
Net Cash $410.53M
Total Debt $252.14M
Cash & Short-Term Investments $660.96M
Total Assets $744.5M
Current Ratio 8.37
Quick Ratio 8.14
Debt / Equity Ratio 0.99
Debt / EBITDA -1.98
Debt / FCF -3.05
OCF / Debt -0.33
Interest Coverage -5.16
Altman Z-Score 1.06
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 93.9%
Operating Profit Margin -81.0%
EBITDA Margin -74.8%
Net Profit Margin -88.2%
FCF Margin -48.7%
Adj. FCF Margin -37.0%
SBC / Revenue -11.7%
SBC Impact (per share) -24.0%
Returns
Return on Assets -20.1%
Return on Equity -49.7%
Return on Invested Capital -20.7%
Return on Capital Employed -20.9%
Return on Tangible Assets -20.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 136.1%
Revenue CAGR 5Y 95.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 78.8%
EPS CAGR 5Y -1.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y 0.7%
FCF CAGR 5Y -7.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 37.2%
Revenue Growth Next 3Y 46.0%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) -$0.12
EPS Growth Est (next Q) -25.0%
Revenue Est (next Q) $35.29M
Revenue Growth Est (next Q) 169.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $20.50
Price Target Upside 237.7%
Cash Flow
Operating Cash Flow $-82.62M
Free Cash Flow $-82.72M
Adj. Free Cash Flow $-62.84M
FCF Per Share -$0.24
OCF Per Share -$0.24
OCF/S Ratio -48.6%
Income Statement
Revenue $169.9M
Gross Profit $159.6M
Operating Income $-137.63M
EBITDA $-127.04M
Net Income $-149.83M
EPS (Diluted) -$0.44
Revenue / Employee $557.05K
Profit / Employee $-491.24K
Employees 305
Add to Watchlist
Select watchlists to add or remove NUVB